Title variants
Languages of publication
Abstracts
Genetically modified organisms are the key step for innovative medicines. The innovative drugs in the 21st century will be in the majority of proteins, nucleic acids and their combinations. The critical issues in case of biopharmaceuticals are quality and reproducibility of production. These aspects are evident in biosimilars (generics) and protection of intellectual property rights.
Keywords
Discipline
Journal
Year
Issue
Pages
5-10
Physical description
Contributors
author
References
Document Type
MONOGRAPHY
Publication order reference
Tomasz Twardowski, Instytut Chemii Bioorganicznej, Polska Akademia Nauk, ul. Noskowskiego 12/14, Poznan, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-38f34d9b-98b2-31e3-8b95-0e9bf756cb86